Johnson & Johnson Aktie

146.65 CHF 1.32CHF 0.91%
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>

Aktionärsstruktur

Inhaber in %
Freefloat 99.86
Vanguard Group, Inc. (Subfiler) 8.42
The Vanguard Group, Inc. 8.08
State Street Corp. 5.74
Vanguard Total Stock Market Index Fund 2.82
BlackRock Institutional Trust Co. NA 2.52
BlackRock Fund Advisors 2.33
Vanguard 500 Index Fund 1.99
State Farm Investment Management Corp. 1.44
Geode Capital Management LLC 1.40
Northern Trust Corp. 1.31
Spdr S&p 500 Etf 1.11
Norges Bank (13F) 1.01
Massachusetts Financial Services Co. 1.00
Wellington Management Co. LLP 0.99

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2015 2016 2017 2018 2019
Personal am Ende des Jahres 127'100 126'400 134'000 135'100 0
Umsatz pro Mitarbeiter in Mio. EUR 0.55 0.57 0.57 0.60 0.00

Bilanz (in Mio. EUR) - Aktiva

2015 2016 2017 2018 2019
Summe Umlaufvermögen 60'210 65'032 43'088 46'033 0
Summe Anlagevermögen 91'011 97'544 94'741 90'232 0
Summe Aktiva 133'411 141'208 157'303 152'954 0

Bilanz (in Mio. EUR) - Passiva

2015 2016 2017 2018 2019
Gesamtverschuldung/ -verbindlichkeiten 19'861 27'126 34'581 30'480 0
Summe Fremdkapital 62'261 70'790 97'143 93'202 0
Summe Eigenkapital 71'150 70'418 60'160 59'752 0
Summe Passiva 133'411 141'208 157'303 152'954 0

Adresse

One Johnson & Johnson Plaza, 08933 New Brunswick
Telefon +1 (732) 524-0400
Internet http://www.jnj.com

Management

A. Eugene Washington
Independent Director
Alex Gorsky
Chairman & Chief Executive Officer
Anne M. Mulcahy
Lead Independent Director
Charles O. Prince
Independent Director
Chris DelOrefice
Vice President-Investor Relations
Ciro Römer
Company Group Chairman
D. Scott Davis
Independent Director
Euan Stuart Thomson
Global Head-Digital Technology
Hubert Joly
Director
Ian Edward Lamert Davis
Independent Director
James D. Swanson
Global Chief Information Officer & Executive VP
Jason Valmore
Vice President-Corporate Internal Audit
Jennifer A. Doudna
Independent Director
Jennifer Taubert
EVP & Worldwide Chairman-Pharmaceuticals
Joaquin Duato
Vice Chairman-Executive Committee
Joseph J. Wolk
Chief Financial Officer & Executive Vice President
Lawrence M. Blatt
Global Therapeutic Area Head, Infectious Diseases
Lisa Romanko
Senior Director-Investor Relations
Liz Fowler
Vice President-Global Health Policy
Marillyn A. Hewson
Director
Mark Alan Weinberger
Director
Mark B. McClellan
Independent Director
Mary C. Beckerle
Independent Director
Mathai Mammen
Head-Science & Development
Matthew Orlando
Secretary
Matthew Stuckley
Senior Finance Director
Michael H. Ullmann
Executive Vice President & General Counsel
Paulus Stoffels
Chief Scientific Officer
Peter M. Fasolo
Chief Human Resources Officer & Executive VP
Peter Shen
Global Head-Research & Development
Robert J. Decker
Chief Accounting Officer
Ronald A. Kapusta
Chief Accounting Officer & Controller
Ronald A. Williams
Independent Director
Sarah L. Colamarino
Vice President-Corporate Equity
Scott White
Company Group Chairman
Thomas J. Spellman
Secretary
William David Perez
Independent Director
William E. Cohn
Director-Center for Device Innovation

Eintrag hinzufügen

;